Scopus BioPharma's Subsidiary - Duet BioTherapeutics - Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
Stock Information for Scopus BioPharma Inc.
Loading
Please wait while we load your information from QuoteMedia.